Oppenheimer USA reported $466.43M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Bank Of America USD 30.3B 1.9B Mar/2026
Barclays GBP 8.16B 1.08B Mar/2026
BGC Partners USD 955.5M 199.13M Mar/2026
Canaccord Genuity CAD 616.13M 85.71M Dec/2025
Citigroup USD 24.63B 4.73B Mar/2026
Deutsche Bank EUR 8.67B 945M Mar/2026
Evercore Partners USD 1.4B 120M Mar/2026
Goldman Sachs USD 17.23B 3.78B Mar/2026
JPMorgan USD 50.54B 3.77B Mar/2026
Matsui Securities JPY 15.37B 1.92B Mar/2026
Moelis & Company USD 319.8M 168.1M Mar/2026
Morgan Stanley USD 20.58B 2.68B Mar/2026
Oppenheimer USA USD 466.43M 149.79M Dec/2025
Piper Sandler Companies USD 474.14M 191.91M Mar/2026
Prospect Capital USD 150.07M 25.93M Mar/2026
Raymond James Financial USD 3.86B 120M Mar/2026
Reinet Investments EUR 427M 301M Dec/2025
Scully Royalty CAD 18.56M 7.95M Jun/2025
Stifel Financial USD 1.48B 80M Mar/2026
Transnational Corp Of Nigeria NGN 130.71B 3.05B Dec/2025
UMB Financial USD 739.2M 18.3M Mar/2026
Wells Fargo USD 21.4B 110M Mar/2026
XP BRL 4.95B 10M Dec/2025